Physician profile
Cheryl Lee
NPI 1053611400
$1,434.16
in general payments reported to CMS, 2019-2025
14 companies · $19.14 in 2025
The $19.14 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $317 · 2020: $175 · 2021: $208 · 2022: $195 · 2023: $104 · 2024: $417 · 2025: $19.14.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $508 · Education: $31.10.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $508.17 |
| Education | $31.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $357.67 | 2019-2021 | |
| Regeneron Healthcare Solutions, INC. | $259.68 | 2019-2023 | Eylea |
| Abbvie INC. | $252.12 | 2023-2024 | |
| Amgen INC. | $125.00 | 2024 | Tepezza |
| Novartis Pharmaceuticals Corporation | $107.86 | 2019 | |
| Oyster Point Pharma, INC. | $95.78 | 2022 | |
| Sun Pharmaceutical Industries INC. | $74.05 | 2024 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $52.85 | 2020 | |
| Eyepoint US, INC. | $24.07 | 2023 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Johnson & Johnson Vision Care, INC. | $19.14 | 2025 | |
| Glaukos Corporation | $17.58 | 2019 | |
| Aerie Pharmaceuticals, INC. | $15.17 | 2021 | |
| Johnson & Johnson Surgical Vision, INC. | $13.79 | 2023 | Veritas Vision System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cheryl Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.